US Biotech Funding, Rising M&A Signal Gradual CDMO Revival: Nandini Piramal
Published on: March 5, 2026, 12:59 p.m. | Source: Outlook Business
"We are also seeing improvement in US biotech funding, as well as higher M&A and IPO activity, which are leading indicators for CDMO demand," Piramal Pharma Chair told Outlook Business in an exclusive interview
